Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 200 #1
TickerHGSH [NASD]
CompanyChina HGS Real Estate Inc.
CountryChina
IndustryReal Estate Development
Market Cap256.78MEPS (ttm)0.72
P/E7.92EPS this Y56.50%
Forward P/E-EPS next Y-
PEG-EPS past 5Y20.80%
P/S2.20EPS next 5Y-
P/B1.96EPS Q/Q6.30%
Dividend-Sales Q/Q3.90%
Insider Own69.88%Inst Own0.30%
Insider Trans-Inst Trans174.97%
Short Float1.13%EarningsDec 20
Analyst Recom-Target Price-
Avg Volume172.63K52W Range2.10 - 10.50
Dec-18-14 01:04PMCHINA HGS REAL ESTATE INC. Financials EDGAR Online Financials
Dec-15-14 07:05AMQuarterly Changes to the NASDAQ Golden Dragon China Index GlobeNewswire
Dec-12-14 04:31PMBiggest Gainers From Friday, December 12, 2014 Benzinga
Dec-12-14 07:31AMCHINA HGS REAL ESTATE INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
Dec-12-14 07:00AMChina HGS Reports Full Year Financial Results for the Fiscal Year 2014 - Revenue and Net Profit Up by Approximately 83% and 56%, Respectively PR Newswire
Dec-12-14 06:19AMCHINA HGS REAL ESTATE INC. Files SEC form 10-K, Annual Report EDGAR Online
Sep-29-14 04:31PMCHINA HGS REAL ESTATE INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Sep-23-14 01:03PM3 Real Estate Stocks Nudging The Industry Higher at TheStreet
Sep-02-14 11:08AMWhy China HGS Real Estate (HGSH) Stock Is Up Today at TheStreet
Sep-02-14 07:30AMCHINA HGS REAL ESTATE INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
China HGS Real Estate, Inc., through its subsidiary, Shaanxi Guangsha Investment and Development Group Co., Ltd, develops real estate properties in the People's Republic of China. It is involved in the construction and sale of residential apartments, parking lots, and commercial properties. The company develops commercial and residential projects, including multi-layer, sub-high-rise, and high-rise apartment buildings, as well as office buildings. China HGS Real Estate, Inc. was founded in 1995 and is headquartered in Hanzhong, the People's Republic of China.
TickerFATE [NASD]
CompanyFate Therapeutics, Inc.
CountryUSA
IndustryBiotechnology
Market Cap108.40MEPS (ttm)-1.25
P/E-EPS this Y72.90%
Forward P/E-EPS next Y-3.20%
PEG-EPS past 5Y0.00%
P/S-EPS next 5Y-
P/B3.21EPS Q/Q93.30%
Dividend-Sales Q/Q-
Insider Own33.43%Inst Own81.40%
Insider Trans-0.59%Inst Trans2.54%
Short Float0.27%EarningsNov 11
Analyst Recom1.80Target Price12.67
Avg Volume16.35K52W Range3.50 - 13.55
Dec-18-14 07:31AMFATE THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Dec-18-14 07:01AMFate Therapeutics Announces Interim Data From Ongoing Phase 2 PUMA Study GlobeNewswire
Dec-08-14 01:00PMFate Therapeutics Highlights Effects of Nutrient-Rich Media on Ex Vivo Programmed CD34+ Cells Sourced From Umbilical Cord Blood GlobeNewswire
Dec-06-14 12:00PMFate Therapeutics Unveils Preclinical Findings of Newly-Identified Small Molecule Modulator Combination for Ex Vivo Programming of Mobilized Peripheral Blood GlobeNewswire
Nov-25-14 04:01PMFate Therapeutics to Present at Piper Jaffray 26th Annual Healthcare Conference GlobeNewswire
Nov-24-14 01:00PMWarren Buffett Pick CBI Tumbles On Rating Downgrade at TheStreet
Nov-21-14 01:04PMFATE THERAPEUTICS INC Financials EDGAR Online Financials
Nov-19-14 06:07AMFate Therapeutics (FATE) Catches Eye: Stock Adds 6.4% in Session Zacks
Nov-17-14 06:01AMFATE THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
Nov-12-14 09:01AMFATE THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops pharmacologic modulators of adult stem cells to treat orphan diseases. Its hematopoietic stem cell (HSC) modulation platform focuses on the ex vivo pharmacologic optimization of hematopoietic stem cells, which are adult stem cells that regenerate various types of blood cells throughout a person's lifespan; and satellite cell modulation platform focuses on the in vivo pharmacologic activation of satellite stem cells that are adult stem cells that regenerate muscle throughout a person's lifespan. The company's lead product candidate includes ProHema, a pharmacologically-modulated HSC therapeutic derived from umbilical cord blood that is in Phase II clinical development for hematologic malignancies. It is developing pharmacologically optimized HSC therapeutics for the treatment of lysosomal storage disorders within the central nervous system; and Wnt7a Analogs that is in preclinical studies for regeneration in muscular dystrophies. Fate Therapeutics, Inc. was founded in 2007 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Flynn Peter DSee remarksJun 12Option Exercise1.615,4718,8089,510Jun 12 05:45 PM
Flynn Peter DSee remarksJun 12Sale7.005,47138,2974,039Jun 12 05:45 PM
Flynn Peter DSee remarksJun 11Option Exercise1.631,0171,6585,056Jun 12 05:45 PM
Flynn Peter DSee remarksJun 11Sale7.001,0177,1194,039Jun 12 05:45 PM
Flynn Peter DSee remarksJun 10Option Exercise1.636991,1395,389Jun 11 05:58 PM
TickerTRXC [AMEX]
CompanyTransEnterix, Inc.
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap204.61MEPS (ttm)-0.93
P/E-EPS this Y84.40%
Forward P/E-EPS next Y17.10%
PEG-EPS past 5Y-8.10%
P/S409.21EPS next 5Y-
P/B1.57EPS Q/Q83.00%
Dividend-Sales Q/Q-83.10%
Insider Own0.10%Inst Own67.60%
Insider Trans116.64%Inst Trans1.07%
Short Float1.80%EarningsNov 06/b
Analyst Recom1.70Target Price6.04
Avg Volume166.21K52W Range1.40 - 14.00
Dec-19-14 04:08PMTRANSENTERIX INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Dec-19-14 07:30AMTransEnterix Completes Successful Pre-Clinical Robotic Surgical Procedures; Management Affirms FDA Timeline Business Wire
Dec-11-14 07:49AMTRANSENTERIX INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
Dec-11-14 07:30AMTransEnterix, Inc. Appoints William N. Kelley, M.D. to Board of Directors Business Wire
Nov-19-14 04:30PMTransEnterix, Inc. to Present at the 2014 Piper Jaffray Healthcare Conference Business Wire
Nov-15-14 01:04PMTRANSENTERIX INC. Financials EDGAR Online Financials
Nov-12-14 05:04PMTRANSENTERIX INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online
Nov-07-14 04:18PMTransEnterix, Inc. Reports Resignation of Chief Operating Officer Business Wire
Nov-07-14 04:17PMTRANSENTERIX INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
Nov-07-14 04:07PMTRANSENTERIX INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
TransEnterix, Inc., a medical device company, focuses on the development and commercialization of a robotic assisted surgical system in the United States. The company is primarily developing SurgiBot system, a reduced incision, patient-side robotic assisted surgery system. It also offers SPIDER surgical system, which accommodates a range of flexible instruments through articulating instrument delivery tubes; and working channels that enable the use of rigid instruments. In addition, the company develops and manufactures flexible and rigid laparoscopic surgical instruments, such as scissors, graspers, clip appliers, and suction and irrigation instruments that are used in abdominal surgery with the SPIDER system. TransEnterix, Inc. is based in Morrisville, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SLATTERY JOSEPH PEVP and CFOOct 02Option Exercise0.0066,6660116,666Oct 03 07:41 PM
SLATTERY JOSEPH PEVP and CFOOct 02Sale4.1933,000138,27083,666Oct 03 07:41 PM
Mueller RichardChief Operating OfficerSep 08Sale3.603,00010,8090Sep 08 08:00 PM
Mueller RichardChief Operating OfficerSep 04Option Exercise0.353,0001,0503,000Sep 08 08:00 PM
TickerCORI [NASD]
CompanyCorium International, Inc.
CountryUSA
IndustryBiotechnology
Market Cap141.93MEPS (ttm)-0.55
P/E-EPS this Y-19.30%
Forward P/E-EPS next Y9.20%
PEG-EPS past 5Y0.00%
P/S3.35EPS next 5Y-
P/B12.08EPS Q/Q-337.50%
Dividend-Sales Q/Q-11.20%
Insider Own0.10%Inst Own84.80%
Insider Trans-5.90%Inst Trans-0.27%
Short Float0.06%EarningsNov 17/a
Analyst Recom1.40Target Price9.80
Avg Volume25.85K52W Range4.30 - 8.49
Dec-20-14 01:04PMCORIUM INTERNATIONAL, INC. Financials EDGAR Online Financials
Dec-15-14 05:32PMCORIUM INTERNATIONAL, INC. Files SEC form 10-K, Annual Report EDGAR Online
Dec-08-14 04:32PMCORIUM INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex EDGAR Online
Dec-08-14 04:05PMCorium Announces Appointment of Ivan Gergel, M.D. to Board of Directors GlobeNewswire
Dec-04-14 04:05PMCorium Announces Closing of Expanded Term Loan Facility With CRG GlobeNewswire
Nov-20-14 04:06PMCORIUM INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material EDGAR Online
Nov-19-14 07:31AMCorium International (CORI) Jumps: Stock Moves 14.3% Higher Zacks
Nov-17-14 04:17PMCORIUM INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
Nov-17-14 04:05PMCorium Reports Fiscal Year-End 2014 Financial Results and Recent Corporate Developments GlobeNewswire
Nov-17-14 07:07AMQ4 2014 Corium International Inc Earnings Release - After Market Close CCBN
Corium International, Inc., a biopharmaceutical company, focuses on the research, development, manufacture, and commercialization of specialty pharmaceutical products. Its products include Clonidine Transdermal Delivery System (TDS), a treatment for hypertension; Fentanyl TDS, a treatment for management of chronic pain, including cancer-related pain; Crest Whitestrips, a series of four products under the Advanced Vivid, Professional Effects, One Hour Express, and Flex-Fit brands for oral care. The company is also developing AG200-15, a combination hormonal contraceptive patch in Phase III clinical trials that delivers ethinyl estradiol and levonorgestrel hormones; MicroCor hPTH(1-34), a transdermal system, which has completed Phase I clinical trials for the treatment of severe osteoporosis; and Corplex Tamsulosin that has completed Phase I clinical trials for the treatment of benign prostatic hyperplasia. In addition, its products that have completed development, scale-up, and clinical activities include motion sickness patch for the prevention of nausea and vomiting associated with motion sickness; and urology patch for treatment of a urologic condition. Further, the company is developing Donepezil and Memantine transdermal patches for the treatment of Alzheimer's disease; and Ropinerole and Pramipexole therapies for the treatment of Parkinson's disease. Corium International, Inc. has collaboration agreements with The Procter & Gamble Company, Teva Pharmaceuticals USA, Inc., Par Pharmaceutical, Inc., and Agile Therapeutics, Inc. The company was incorporated in 1995 and is headquartered in Menlo Park, California.
TickerSFY [NYSE]
CompanySwift Energy Co.
CountryUSA
IndustryIndependent Oil & Gas
Market Cap206.58MEPS (ttm)-0.60
P/E-EPS this Y-191.70%
Forward P/E-EPS next Y-1006.20%
PEG-EPS past 5Y44.50%
P/S0.35EPS next 5Y5.00%
P/B0.19EPS Q/Q-64.70%
Dividend-Sales Q/Q-8.00%
Insider Own1.00%Inst Own-
Insider Trans4.78%Inst Trans0.44%
Short Float36.36%EarningsNov 06/b
Analyst Recom2.70Target Price6.98
Avg Volume2.63M52W Range2.61 - 14.25
Nov-25-14 01:04PMSWIFT ENERGY CO Financials EDGAR Online Financials
Nov-20-14 10:02AMSwift Energy (SFY) Strong On High Relative Volume Today at TheStreet
Nov-19-14 07:07PM10-Q for Swift Energy Co. Company Spotlight
Nov-18-14 03:48PMLifshitz & Miller Law Firm Announces Investigation of Allergan, Inc., Baker Hughes Incorporated, ChyronHego Corp., Horizon Lines, Inc., Susquehanna Bancshares, Inc., Swift Energy Company and Valley Financial Corporation PR Newswire
Nov-17-14 06:58PMSwift Energy Files Restated 2013 Full-Year and 2014 Quarterly Financial Reports and Files Initial Third Quarter 2014 Report Business Wire
Nov-17-14 04:13PMSWIFT ENERGY CO Files SEC form 10-Q/A, Quarterly Report EDGAR Online
Nov-17-14 04:02PMSWIFT ENERGY CO Files SEC form 10-K/A, Annual Report EDGAR Online
Nov-14-14 08:30PMHarwood Feffer LLP Announces Investigation of Swift Energy Co. PR Newswire
Nov-13-14 06:14PMInvestor Alert: Investigation into Swift Energy Co. Announced by Holzer & Holzer, LLC Business Wire
Nov-13-14 05:48PMRobbins Arroyo LLP Is Investigating the Officers and Directors of Swift Energy Co. (SFY) on Behalf of Shareholders PR Newswire
Swift Energy Company is engaged in acquiring, exploring, developing, and operating oil and natural gas properties. It focuses on oil and natural gas reserves in Texas, as well as onshore and in the inland waters of Louisiana. As of December 31, 2013, the company had estimated proved reserves of 219.2 million barrels of oil equivalent. Swift Energy Company was founded in 1979 and is headquartered in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
VINCENT BRUCE HPresidentDec 16Sale2.961,6004,738297,018Dec 18 06:49 PM
SWIFT TERRY ECOB & CEOAug 05Buy10.9720,000219,382447,396Aug 05 09:21 PM
MATIUK GREGDirectorMar 18Buy10.0415,000150,58455,880Mar 20 04:14 PM
SMITH CLYDE W JRDirectorMar 13Buy9.6215,000144,35771,271Mar 13 06:07 PM
TickerPETX [NASD]
CompanyAratana Therapeutics, Inc.
CountryUSA
IndustryBiotechnology
Market Cap570.12MEPS (ttm)-0.68
P/E-EPS this Y31.60%
Forward P/E-EPS next Y-17.50%
PEG-EPS past 5Y0.00%
P/S950.20EPS next 5Y15.00%
P/B2.50EPS Q/Q-59.10%
Dividend-Sales Q/Q-
Insider Own4.10%Inst Own92.00%
Insider Trans0.14%Inst Trans15.03%
Short Float7.10%EarningsOct 06
Analyst Recom1.60Target Price25.25
Avg Volume239.40K52W Range9.20 - 25.50
Dec-18-14 04:52PMAratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis PR Newswire
Dec-16-14 04:28PMAratana Therapeutics Initiates Pivotal Study for AT-003 PR Newswire
Dec-05-14 12:13PMAratana Therapeutics to Present at the 2014 Animal & Dental Health Summit PR Newswire
Nov-28-14 10:52AMAratana Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference PR Newswire
Nov-19-14 01:04PMARATANA THERAPEUTICS, INC. Financials EDGAR Online Financials
Nov-17-14 02:12PMAratana Therapeutics to Present at Jefferies Global Healthcare Conference PR Newswire
Nov-12-14 09:02AMARATANA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-11-14 05:11AMAratana beats 3Q profit forecasts AP
Nov-10-14 05:18PMARATANA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
Nov-10-14 04:31PMAratana Therapeutics Reports Third Quarter 2014 Results PR Newswire
Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, acquisition, development, and commercialization of biopharmaceutical products for cats, dogs, and other companion animals worldwide. Its product portfolio includes approximately 15 product candidates consisting of small molecule pharmaceuticals and large molecule biologics that target various opportunities in serious medical conditions in pets. The company develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a ghrelin agonist for inappetence in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension for the treatment of post-operative pain in cats and dogs. It also develops AT-004, a monoclonal antibody (MAB) used in the treatment of canine B-cell lymphoma; and AT-005, a MAB for the treatment of canine T-cell lymphoma in pets. The company was founded in 2010 and is headquartered in Kansas City, Kansas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rhodes LindaCHIEF SCIENTIFIC OFFICEROct 06Option Exercise6.004,70028,200451,005Oct 08 05:37 PM
St Peter StevenPRESIDENT AND CEOSep 03Option Exercise6.0025,000150,000734,394Sep 04 06:06 PM
St Peter StevenPRESIDENT AND CEOSep 02Sale11.6725,000291,863709,394Sep 04 06:06 PM
STEPHANUS JULIA ACHIEF COMMERCIAL OFFICERJul 03Sale17.332,00034,660119,679Jul 03 04:57 PM
Rhodes LindaCHIEF SCIENTIFIC OFFICERJul 01Sale16.0010,000160,000446,305Jul 03 04:54 PM
TickerMPO [NYSE]
CompanyMidstates Petroleum Company, Inc.
CountryUSA
IndustryIndependent Oil & Gas
Market Cap124.70MEPS (ttm)-5.20
P/E-EPS this Y-132.80%
Forward P/E-EPS next Y-152.50%
PEG-EPS past 5Y0.00%
P/S0.18EPS next 5Y17.50%
P/B0.35EPS Q/Q272.50%
Dividend-Sales Q/Q101.60%
Insider Own0.90%Inst Own75.20%
Insider Trans-0.94%Inst Trans2.15%
Short Float9.42%EarningsNov 04/a
Analyst Recom2.90Target Price3.15
Avg Volume926.74K52W Range1.05 - 7.50
Dec-09-14 06:02AMMIDSTATES PETROLEUM COMPANY, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Other Events, F EDGAR Online
Dec-08-14 04:15PMMidstates Petroleum Announces Termination of DeQuincy Assets Sales Agreement GlobeNewswire
Dec-02-14 04:38PMThese U.S. oil producers have the most to lose at MarketWatch
Dec-01-14 04:15PMMidstates Petroleum to Participate in Cowen and Company Ultimate Energy Conference GlobeNewswire
Nov-15-14 01:04PMMIDSTATES PETROLEUM COMPANY, INC. Financials EDGAR Online Financials
Nov-11-14 07:09AMMidstates Petroleum upgraded by Northland Capital Briefing.com
Nov-11-14 05:50AMWeakness Seen in PetroQuest Energy (PQ) Estimates: Should You Stay Away? Zacks
Nov-07-14 06:03AMPDC Energy (PDCE) in Focus: Stock Falls 5.6% Zacks
Nov-06-14 03:32PMMIDSTATES PETROLEUM COMPANY, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-05-14 10:00AMMidstates Petroleum Company Inc Earnings Call scheduled for 10:00 am ET today CCBN
Midstates Petroleum Company, Inc. is engaged in the exploration, development, and production of oil, natural gas liquids, and natural gas in the United States. It primarily focused on oilfields in the Mississippian Lime trend in northwestern Oklahoma; the Anadarko Basin in Texas and Oklahoma; and the Upper Gulf Coast Tertiary trend in central Louisiana. The company was founded in 1993 and is headquartered in Houston, Texas.
TickerBAS [NYSE]
CompanyBasic Energy Services, Inc.
CountryUSA
IndustryOil & Gas Equipment & Services
Market Cap344.58MEPS (ttm)0.07
P/E114.00EPS this Y-289.40%
Forward P/E63.84EPS next Y-77.19%
PEG19.00EPS past 5Y-20.50%
P/S0.25EPS next 5Y6.00%
P/B0.91EPS Q/Q134.30%
Dividend-Sales Q/Q-58.70%
Insider Own2.50%Inst Own83.70%
Insider Trans-11.26%Inst Trans4.50%
Short Float5.98%EarningsOct 23/a
Analyst Recom2.40Target Price13.79
Avg Volume3.17M52W Range5.01 - 29.84
Dec-19-14 04:48PMBASIC ENERGY SERVICES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex EDGAR Online
Dec-19-14 04:08PMBasic Energy Services (BAS) Stock Closes Higher Today as Oil Prices Rise at TheStreet
Dec-17-14 08:28AMBasic Energy Services upgraded by Howard Weil Briefing.com
Dec-17-14 08:01AMAnother Wave Of Downgrades For Oil Stocks Benzinga
Dec-16-14 10:46AMOil Drillers: 'Pain is Comingand Coming Soon' at Barrons.com
Dec-09-14 06:00AMBasic Energy Services Reports Selected Operating Data For November 2014 PR Newswire
Dec-04-14 06:00AMBasic Energy Services To Present At The Capital One Securities 9th Annual Energy Conference PR Newswire
Dec-03-14 03:02PMBasic Energy Services (BAS) Stock Hits 52-Week Low Today After Analyst Actions at TheStreet
Dec-02-14 09:01AMBASIC ENERGY SERVICES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financ EDGAR Online
Nov-25-14 06:00AMBasic Energy Services To Present At Two Investor Conferences During The First Week Of December PR Newswire
Basic Energy Services, Inc. provides well site services to oil and natural gas drilling and producing companies in the United States. Its Completion and Remedial Services segment provides pumping services, such as cementing, acidizing, fracturing, nitrogen, and pressure testing; rental and fishing tools; coiled tubing; snubbing services; thru-tubing; cased-hole wireline services; and underbalanced drilling in low pressure and fluid sensitive reservoirs. This segment operates 232 pressure pumping units; and 41 air compressor packages, including 37 snubbing units, 14 coiled tubing units, and 12 wireline units. The company's Fluid Services segment is involved in the transportation of fluids; the production of salt water; the sale and transportation of fresh and brine water; the rental of portable frac and test tanks; the recycling and treatment of wastewater; the operation of brine source wells and non-hazardous wastewater disposal wells; and the preparation, construction, and maintenance of access roads, drilling locations, and production facilities. As of December 31, 2013, this segment owned and operated 1,003 fluid service trucks with an average fluid hauling capacity of up to 150 barrels apiece. Its Well Servicing segment provides services performed with a mobile well servicing rig and ancillary equipment, such as maintenance work, hoisting tools and equipment required by the operation, and plugging and abandonment services, as well as manufactures and sells workover rigs. As of December 31, 2013, this segment operated a fleet of 425 well servicing. Its Contract Drilling segment employs drilling rigs and related equipment to penetrate the earth to a desired depth and initiate production. This segment owns and operates 12 land drilling rigs. The company was formerly known as Sierra Well Service, Inc. and changed its name to Basic Energy Services, Inc. in 2000. Basic Energy Services, Inc. was founded in 1992 and is headquartered in Fort Worth, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Krenek AlanSVP, CFO, Secretary, TreasurerNov 25Sale11.261,00011,256146,998Nov 26 05:05 PM
MOORE THOMAS JRDirectorOct 27Buy12.8410,000128,364113,000Oct 29 04:15 PM
Taylor Brett J.VP, Manufacturing & EquipmentOct 27Buy13.003,50045,50050,057Oct 28 04:12 PM
Krenek AlanSVP, CFO, Secretary, TreasurerOct 27Sale12.641,00012,635147,998Oct 28 04:10 PM
Bissett John CodyVP, Controller and CAOOct 01Sale21.491,00021,48945,025Oct 02 04:43 PM
TickerSNFCA [NASD]
CompanySecurity National Financial Corp.
CountryUSA
IndustryCredit Services
Market Cap78.29MEPS (ttm)0.50
P/E11.88EPS this Y-57.90%
Forward P/E-EPS next Y-
PEG-EPS past 5Y63.80%
P/S0.36EPS next 5Y-
P/B0.75EPS Q/Q70.00%
Dividend-Sales Q/Q22.70%
Insider Own6.10%Inst Own7.20%
Insider Trans-0.50%Inst Trans0.74%
Short Float0.48%EarningsNov 12
Analyst Recom-Target Price-
Avg Volume15.02K52W Range3.62 - 5.45
Dec-19-14 06:41PMNasdaq stocks posting largest percentage increases AP
Nov-26-14 01:04PMSECURITY NATIONAL FINANCIAL CORP Financials EDGAR Online Financials
Nov-17-14 07:09PM10-Q for Security National Financial Corp. Company Spotlight
Nov-14-14 12:00PMSecurity National Financial Corporation Reports Financial Results for the Third Quarter of 2014 Business Wire
Nov-14-14 11:32AMSECURITY NATIONAL FINANCIAL CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
Aug-14-14 10:57AMSecurity National Financial Corporation Reports Financial Results for the Second Quarter of 2014 Business Wire
Aug-14-14 10:31AMSECURITY NATIONAL FINANCIAL CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
Jul-16-14 05:12PMSECURITY NATIONAL FINANCIAL CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Jun-13-14 01:37PMSECURITY NATIONAL FINANCIAL CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
May-16-14 12:53PMSecurity National Financial reports Q1 EPS 1c vs. 16c a year ago at theflyonthewall.com
Security National Financial Corporation provides life insurance, cemetery and mortuary services, and mortgage loans. The company's Insurance segment is engaged in selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. It offers various life insurance products, including funeral plans and interest-sensitive life insurance, as well as other traditional life, accident, and health insurance products; and annuity products, such as single premium deferred annuities, flexible premium deferred annuities, and immediate annuities, as well as cedes and assumes certain risks with various authorized unaffiliated reinsurers pursuant to reinsurance treaties. This segment sells its life insurance products through direct agents, brokers, and independent licensed agents. The company's Cemetery and Mortuary segment owns five cemeteries in the state of Utah and one cemetery in the state of California; and seven mortuaries in the state of Utah and one mortuary in the state of Arizona. This segment also markets various products, such as plots, interment vaults, mausoleum crypts and niches, markers, caskets, flowers, and other related products; and offers services comprising professional services of funeral directors, opening and closing of graves, use of chapels and viewing rooms, and use of automobiles and clothing. The company's Mortgage Loan segment originates and underwrites, or purchases residential and commercial loans for new construction, existing homes, and real estate projects. This segment primarily markets its products to real estate brokers and mortgage originators. Security National Financial Corporation was founded in 1965 and is headquartered in Salt Lake City, Utah.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wilbur Norman GDirectorNov 26Sale5.077003,5493,497Dec 01 11:47 AM
Wilbur Norman GDirectorOct 13Sale4.901,7338,4924,197Oct 15 11:05 AM
Wilbur Norman GDirectorAug 25Sale4.532,0009,0535,930Aug 26 04:46 PM
Wilbur Norman GDirectorAug 18Option Exercise1.415,5137,7739,710Aug 21 05:57 PM
Wilbur Norman GDirectorAug 18Sale4.521,7808,0467,930Aug 21 05:57 PM
TickerCRK [NYSE]
CompanyComstock Resources Inc.
CountryUSA
IndustryIndependent Oil & Gas
Market Cap346.03MEPS (ttm)-0.77
P/E-EPS this Y-3.20%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-30.70%
P/S0.63EPS next 5Y20.00%
P/B0.36EPS Q/Q92.30%
Dividend6.92%Sales Q/Q29.90%
Insider Own6.20%Inst Own-
Insider Trans0.07%Inst Trans2.08%
Short Float22.12%EarningsNov 03/a
Analyst Recom2.70Target Price11.07
Avg Volume2.68M52W Range5.01 - 28.86
Dec-18-14 11:18AMCOMSTOCK RESOURCES INC Files SEC form 8-K, Other Events EDGAR Online
Dec-18-14 09:11AMComstock Resources, Inc. Announces 2015 Exploration and Development Budget Thomson Reuters ONE
Dec-08-14 11:30AMComstock Resources Profits Hit by Production, Pricing Woes Zacks
Dec-02-14 11:04AMComstock downgraded by Global Hunter Securities Briefing.com
Dec-01-14 06:01AMWhy Comstock Resources (CRK) Could Be Positioned for a Slump Zacks
Nov-28-14 10:01AMComstock Resources (CRK) Weak On High Volume at TheStreet
Nov-24-14 10:13AMComstock Resources (CRK) Showing Signs Of Perilous Reversal Today at TheStreet
Nov-19-14 09:14AMCOMSTOCK RESOURCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Stateme EDGAR Online
Nov-19-14 09:11AMComstock Resources, Inc. Announces New Vice President of Land Thomson Reuters ONE
Nov-18-14 04:11PMComstock Resources, Inc. Board of Directors Declares Quarterly Dividend Thomson Reuters ONE
Comstock Resources, Inc., an independent energy company, acquires, develops, explores, and produces oil and natural gas properties in the United States. Its oil and gas operations are primarily located in East Texas/North Louisiana and South Texas. The company owns interests in approximately 1,535 producing oil and natural gas wells. As of December 31, 2013, it had proved reserves of 585 billion cubic feet of natural gas equivalent. The company was founded in 1919 and is headquartered in Frisco, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PRESLEY DANIEL KVP of AccountingDec 10Buy5.7110,00057,09999,524Dec 11 03:18 PM
McBurney Michael DVP of MarketingDec 09Buy5.773,00017,31031,000Dec 09 12:36 PM
TURNER JIM LDirectorDec 08Buy5.7050,000284,970104,887Dec 08 05:53 PM
SLEDGE DAVID WDirectorNov 11Buy11.195,00055,95792,958Nov 12 11:15 AM
BURNS ROLAND OPresident & CFONov 07Buy11.264,00045,036818,518Nov 07 08:19 PM
1 2 3 4 5 6 ... 10 ... 20 next